Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Chinnakotla, J. Leone, M. Fidler, M. Hammeke, S. Tarantolo (2000)
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.Transplantation, 70 3
Kathleen Makkar, R. Wilensky, M. Julien, H. Herrmann, S. Spinler (2006)
Rash with Both Clopidogrel and Ticlopidine in Two Patients Following Percutaneous Coronary Intervention with Drug-Eluting StentsAnnals of Pharmacotherapy, 40
E. Amsallem, Christelle Kasparian, G. Haddour, J. Boissel, P. Nony (2005)
Phosphodiesterase III inhibitors for heart failure.The Cochrane database of systematic reviews, 1
H. Rotmensch, P. Vlasses, R. Ferguson (1983)
Resolution of Captopril‐Induced Rash After Substitution of EnalaprilPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 3
N. Farid, C. Payne, D. Small, K. Winters, C. Ernest, J. Brandt, C. Darstein, J. Jakubowski, D. Salazar (2007)
Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics DifferentlyClinical Pharmacology & Therapeutics, 81
P. Sharis, C. Cannon, J. Loscalzo (1998)
The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 129
CL Grines, RO Bonow, DE Casey (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of PhysiciansJ Am Coll Cardiol, 49
M. Bertrand, V. Legrand, J. Boland, E. Fleck, J. Bonnier, Hakan Emmanuelson, M. Vrolix, L. Missault, S. Chierchia, M. Casaccia, L. Niccoli, A. Oto, C. White, M. Webb-peploe, E. Belle, E. Mcfadden (1998)
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.Circulation, 98 16
Juzar Lokhandwala, P. Best, J. Butterfield, K. Skelding, Thomas Scott, J. Blankenship, J. Buckley, P. Berger (2009)
Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.Circulation. Cardiovascular interventions, 2 4
K. Campbell, R. Mallya, Waseem Jaffrani, J. Cohn, D. Fischman, P. Walinsky, M. Savage (2008)
Abstract 4453: Successful Treatment of Clopidogrel Hypersensitivity Without Drug InterruptionCirculation, 118
J. Depta, W. Pichler (2003)
Cross-reactivity with drugs at the T cell levelCurrent Opinion in Allergy and Clinical Immunology, 3
PG Vigo, AL MacDowell, HJ Wedner (2005)
Successful desensitization with clopidogrel after a positive skin test (abstract 44)Ann Allergy Asthma Immunol, 94
Miguel Cámara, F. Almeda (2005)
Clopidogrel (Plavix) desensitization: A case seriesCatheterization and Cardiovascular Interventions, 65
Y. Yoon, W. Shim, D. Lee, W. Pyun, I. Kim, Y. Jang, S. Cho (1999)
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.The American journal of cardiology, 84 12
A. Schömig, Franz‐Josef Neumann, A. Kastrati, H. Schühlen, R. Blasini, M. Hadamitzky, H. Walter, E. Zitzmann-Roth, G. Richardt, E. Alt, C. Schmitt, K. Ulm (1996)
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.The New England journal of medicine, 334 17
D. Clement (1996)
A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 348
C. Grines, Robert Bonow, Donald Casey, Timothy Gardner, Peter Lockhart, D. Moliterno, Patrick O'Gara, Patrick Whitlow (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American DCirculation, 115 6
J. Jakubowski, K. Winters, H. Naganuma, L. Wallentin (2007)
Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.Cardiovascular drug reviews, 25 4
M. Doogue, E. Begg, P. Bridgman (2005)
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia.Mayo Clinic proceedings, 80 10
W. Ray (2003)
Population-based studies of adverse drug effects.The New England journal of medicine, 349 17
C. Grines, Robert Bonow, Donald Casey, Timothy Gardner, Peter Lockhart, David Moliterno, Patrick O'Gara, Patrick Whitlow (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American DJournal of the American College of Cardiology, 49 6
K Campbell, R Mallya, W Jaffrani (2008)
Treatment of clopidogrel hypersensitivity without drug interruptionCirculation, 118
M. Fajt, A. Petrov (2010)
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization RegimenAnnals of Pharmacotherapy, 44
M. Leon, D. Baim, J. Popma, P. Gordon, D. Cutlip, K. Ho, A. Giambartolomei, D. Diver, D. Lasorda, David Williams, S. Pocock, R. Kuntz (1998)
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingThe New England Journal of Medicine, 339
N. Walker, M. Fasano, Phillip Horwitz (2006)
Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.The Journal of invasive cardiology, 18 7
DA Morrow, SD Wiviott, HD White (2009)
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarctionCirculation, 119
M. Dennis (1996)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeThe Lancet, 348
Karl Tiehl, M. Price, R. Valencia, Katherine Ludington, P. Teirstein, R. Simon (2007)
Clopidogrel desensitization after drug-eluting stent placement.Journal of the American College of Cardiology, 50 21
Clopidogrel is a widely used antiplatelet agent, particularly after coronary stent implantation. About 1% of patients have allergic or hematologic adverse reactions to clopidogrel. This has important therapeutic implications, as premature discontinuation of clopidogrel is the strongest risk factor for stent thrombosis. Clopidogrel allergy most commonly manifests as a rash. It is important to distinguish this from other causes of rash occurring in patients who have had a recent coronary stent. Although antihistamines and short-term oral corticosteroids are effective in treating most clopidogrel hypersensitivity reactions, some persistent reactions may require discontinuation of clopidogrel. When discontinuation of clopidogrel is required, substitution with an alternative thienopyridine such as ticlopidine traditionally has been performed. However, a recent study suggests that there may be as high as a 27% risk of recurrence of non-life-threatening allergic reactions in such patients, which are usually similar to the allergic reactions that occurred with clopidogrel. No data are available regarding the frequency of cross-reactivity to prasugrel and ticagrelor; these may be potential therapeutic options in some patients.
Current Allergy and Asthma Reports – Springer Journals
Published: Oct 13, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.